切换至 "中华医学电子期刊资源库"

中华腔镜外科杂志(电子版) ›› 2020, Vol. 13 ›› Issue (04): 223 -228. doi: 10.3877/cma.j.issn.1674-6899.2020.04.007

所属专题: 文献资源库

论著 上一篇    下一篇

腹腔镜骶骨固定术相关并发症的回顾:7年单中心临床分析
赵成志 1, 卢深涛 1, 王荥 1, 刘明博 1, 孙玉菡 1, 雷丽 1, 刘禄斌 1 , ( )   
  1. 1. 400021 重庆市妇幼保健院妇科盆底与肿瘤科
  • 收稿日期:2020-04-07 出版日期:2020-08-30
  • 通信作者: 刘禄斌
  • 基金资助:
    重庆市自然科学基金(cstc2019jcyj-msxm0877); 重庆市技术创新与应用示范(社会民生类一般)项目(cstc2018jscx-msyb0800)

Complications associated with laparoscopic sacral fixation: a 7-year single center clinical analysis

Chengzhi Zhao 1, Shentao Lu 1, Ying Wang 1, Mingbo Liu 1, Yuhan Sun 1, Li Lei 1, Lubin Liu 1 , ( )   

  1. 1. Gynecology Pelvic Floor and Oncology Department Chongqing Maternal and Child Health Hospital, Chongqing 400021, China
  • Received:2020-04-07 Published:2020-08-30
  • Corresponding author: Lubin Liu
  • About author:
    Corresponding author: Liu Lubin, Email:
目的

回顾性分析重庆市妇幼保健院行腹腔镜骶骨固定术7年的临床资料,分析总结该术式的相关并发症及处理。

方法

收集2012年1月至2019年11月接受腹腔镜骶骨固定术的238例患者的临床随访资料,统计分析手术前后POP-Q的Ba、Bp、C、D位点等各指示点及生存质量和性生活状态评分的变化,术后各类并发症的处理情况。

结果

腹腔镜骶骨固定术治疗中盆腔缺陷的有效方式,其治愈率为98.74%;Ba、Bp、C、D位点,以及PFDI-20和PISQ-12问卷均有明显改善,术后生存质量及性生活状态改善。术后的并发症发生率约15.55%,其中便秘发生率最高(约5.04%),其次为疼痛3.78%,网片暴露、新发尿失禁、骶前出血、尿潴留的发生率均1.26%;复发、严重感染发生率0.84%,性生活障碍、输尿管折叠梗阻、尿道损伤发生率0.42%;所有并发症均经相应处理治愈。

结论

腹腔镜骶骨固定术是治疗中盆腔缺陷的有效方式,效果满意,但需重视手术网片并发症的预防及处理,对并发症的合理治疗可以改善患者的预后。

Objective

To analyze the clinical data of laparoscopic sacral fixation in our hospital for 7 years, analyze and summarize the related complications and treatment.

Methods

The clinical follow-up data of 238 patients who underwent laparoscopic sacral fixation from Jan. 2012 to Nov. 2019 in the department of gynecology and pelvic floor and oncology of Chongqing maternal and child health hospital were collected, and the changes of Ba, Bp, C, D and other indicators of POP-Q before and after the operation, the quality of life and the score of sexual activity, and the treatment of various complications and complications after the operation were statistically analyzed.

Result

Laparoscopic sacral fixation can treat pelvic organ prolapse with pelvic cavity defects, and the quality of life and sexual life improved after operation.The cure rate of all patients receiving sacral fixation is 98.74%, and the incidence of complications is about 15.55%.The incidence of constipation is about 5.04%, followed by pain, 3.78%, net exposure, new urinary incontinence, presacral bleeding and urinary retention. The incidence of recurrence and serious infection was 0.84%, sexual life disorder, ureteral fold obstruction and urethral injury was 0.42%, all complications were cured.

Conclusions

Laparoscopic sacral fixation is an effective method for the treatment of pelvic defects.There are corresponding complications of operation and mesh.Reasonable treatment can improve the prognosis of patients.

图1 238例腹腔镜骶骨固定术患者各术式分布情况
表1 238例腹腔镜骶骨固定术患者一般情况及不同手术类型
表2 238例腹腔镜骶骨固定术患者不同手术类型前后POP-Q各位点[M(IQR)]
表3 238例腹腔镜骶骨固定术患者不同手术类型前后PFDI-20及PISQ-12( ±s)
表3 238例腹腔镜骶骨固定术患者不同手术类型的并发症发生情况
1
Pacquée S, Nawapun K, Claerhout F,et al.Long-term assessment of a prospective cohort of patients undergoing laparoscopic sacrocolpopexy[J].Obstet Gynecol,2019,134(2): 323-332.
2
王延洲,梁志清.腹腔镜下盆底结构重建经验与思考[J/CD].中华腔镜外科杂志(电子版),2019,12(5): 264-266.
3
Elneil S, Cutner AS, Remy M,et al.Abdominal sacrocolpopexy for vault prolapse without burial of mesh:a case series[J].BJOG,2005,112(4): 486-489.
4
Karon M, Chatterjee S.Sacrocolpopexy: patient outcomes support the use of non-crosslinked acellular dermal matrix as an alternative to the synthetic polypropylene mesh[J].J Gynecol Surg,2019,35(6): 337-344.
5
De Tayrac R, Sentilhes L.Complications of pelvic organ prolapse surgery and methods of prevention[J].Int Urogynecol J Pelvic Floor Dysfunct,2013,24(11): 1859-1872.
6
Filmar GA, Fisher HW, Aranda E,et al.Laparoscopic uterosacral ligament suspension and sacral colpopexy:results and complications[J].Int Urogynecol J,2014,25(12): 1645-1653.
7
Theobald P, Chéret Angélique. Laparoscopic sacrocolpopexy: results of a 100-patient series with 8 years follow-up[J]. Gynecological Surgery, 2004, 1(1): 31-36.
8
North CE, Ali-Ross NS, Smith AR,et al.A prospective study of laparoscopic sacrocolpopexy for the management of pelvic organ prolapse[J].BJOG,2009, 116(9): 1251-1257.
9
Nygaard IE, McCreery R, Brubaker L,et al.Abdominal sacrocolpopexy: a comprehensive review[J].Obstet Gynecol,2004,104(4): 805-823.
10
Vincent Misraï, Morgan Rouprêt, Florence Cour,et al.De novo urinary stress incontinence after laparoscopic sacral colpopexy[J].BJU Int,2008,101(5): 594-597.
11
Rozet F, Mandron E, Arroyo C,et al.Laparoscopic sacralcolpopexy approach for genito-urinary prolapse: experience with 363 cases[J].Eur Urol,2005, 47(2): 230-236.
12
Braun NM, Andraos W, Bettin S.Safety and efficacy of spider anchoring device for apical repair in laparoscopic sacrocolpopexy: Retrospective cohort study[J].Eur J Obstet Gynecol Reprod Biol,2019,235(1): 88-92.
13
Ross JW, Preston M.Laparoscopic sacrocolpopexy for severe vaginal vault prolapse:five-year outcome[J].J Minim Invasive Gynecol,2005,12(3): 221-226.
14
Apostolopoulos NV, Alexandraki KI, Gorry A,et al.The early benefits of laparoscopic Sacrocolpopexy[J].J Gynecol Obstet Hum Reprod,2019,48(10): 799-804.
15
Abdullah B, Nomura J, Moriyama S,et al.Clinical and urodynamic assessment in patients with pelvic organ prolapse before and after laparoscopic sacrocolpopexy[J].Int Urogynecol J,2017,28(10): 1543-1549.
16
Daneshgari F, Kong W, Swartz M.Complications of mid urethral slings: important outcomes for future clinical trials[J].J Urol,2008,180(5): 1890-1897.
17
Braun NM, Andraos W, Bettin S.Safety and efficacy of spider anchoring device for apical repair in laparoscopic sacrocolpopexy: retrospective cohort study[J].Eur J Obstet Gynecol Reprod Biol,2019,235(1): 88-92.
18
Danford JM, Osborn DJ, Reynolds WS,et al.Postoperative pain outcomes after transvaginal mesh revision[J].Int Urogynecol J,2015,26(1): 65-69.
19
Eisenberg VH, Steinberg M, Weiner Z,et al.Long-term follow-up of sacrocolpopexy mesh implants at two time intervals at least 1 year apart using 4D transperineal ultrasound[J].Ultrasound Obstet Gynecol,2017,49(3): 398-403.
20
Tan-Kim J, Menefee SA, Luber KM,et al.Prevalence and risk factors for mesh erosion after laparoscopic-assisted sacrocolpopexy[J].Int Urogynecol J,2011,22(2): 205-212.
21
Osmundsen BC, Clark A, Goldsmith C,et al.Mesh erosion in robotic sacrocolpopexy[J].Female Pelvic Med Reconstr Surg,2012,18(2): 86-88.
22
Nygaard I, Brubaker L, Zyczynski HM,et al.Long-term outcomes following abdominal sacrocolpopexy for pelvic organ prolapse[J].JAMA,2013,309(19): 2016-2024.
23
Stepanian AA, Miklos JR, Moore RD,et al.Risk of mesh extrusion and other mesh-related complications after laparoscopic sacral colpopexy with or without concurrent laparoscopic-assisted vaginal hysterectomy: experience of 402 patients[J].J Minim Invasive Gynecol,2008,15(2): 188-196.
24
Boyd B, Pratt T, Mishra K.Fungal lumbosacral osteomyelitis after robotic-assisted laparoscopic sacrocolpopexy[J].Female Pelvic Med Reconstr Surg,2018,24(6): 46-48.
25
Zebede S, Dawood A, Alarab M,et al.A streamlined surgical approach to laparoscopic sacrocolpopexy for post-hysterectomy vault prolapse[J].J Obstet Gynaecol Can,2016,38(5): 446-452.
26
张晓薇,陈礼全.阴道-骶骨固定术手术区域应用解剖研究[J].中国实用妇科与产科杂志,2009,25(8): 590-593.
27
Braley SC, Schneider PD, Bold RJ,et al.Controlled tamponade of severe presacral venous hemorrhage: use of a breast implant sizer[J].Dis Colon Rectum,2002,45(1): 140-142.
[1] 陈佳艺. 2020年乳腺癌放射治疗研究年度回顾[J]. 中华乳腺病杂志(电子版), 2021, 15(1): 38-38.
[2] 陈宇翔, 黄群, 闫怡轩, 张彦, 尚宁, 李兵. 先天性唇腭裂三级综合防治及规范化序列治疗指引[J]. 中华口腔医学研究杂志(电子版), 2021, 15(04): 193-197.
[3] 刘德朗, 陈世远. 无症状腹主动脉瘤治疗进展[J]. 中华普通外科学文献(电子版), 2021, 15(05): 391-394.
[4] 马懿迪, 王素美. 疝外科网片在盆腔脏器脱垂治疗中的应用现状及展望[J]. 中华疝和腹壁外科杂志(电子版), 2021, 15(04): 325-328.
[5] 张凡, 汪学艳, 白琪, 王博方, 李玉民, 陈昊. 肝门部胆管癌术前评估和处理[J]. 中华肝脏外科手术学电子杂志, 2021, 10(05): 446-448.
[6] 刘忠涛, 文宇, 何超. ERCP在胆管良性狭窄中的诊治现状与进展[J]. 中华肝脏外科手术学电子杂志, 2021, 10(05): 454-458.
[7] 严庆, 冯铭彬, 朱太峰, 许磊波, 刘超. 术后辅助化疗对肝门部胆管癌切除术后患者预后的影响[J]. 中华肝脏外科手术学电子杂志, 2021, 10(05): 459-463.
[8] 张硕, 杨军, 顾元龙. 腹腔镜胆囊切除术致胆道损伤的危险因素及处理[J]. 中华肝脏外科手术学电子杂志, 2021, 10(05): 470-473.
[9] 朱磊, 顾洪柱, 李珊珊, 李雨成. 辅助化疗在预防胰腺导管腺癌术后早期复发中的应用价值[J]. 中华肝脏外科手术学电子杂志, 2021, 10(05): 484-488.
[10] 林颖, 林显艺, 陈荣, 潘雪梅. ERCP在胆囊切除术后胆总管结石治疗中的应用[J]. 中华肝脏外科手术学电子杂志, 2021, 10(05): 502-505.
[11] 陈立华, 孙恺, 陈文锦, 夏勇, 张洪钿, 徐如祥. 儿童髓母细胞瘤的风险分层治疗[J]. 中华神经创伤外科电子杂志, 2021, 07(04): 242-246.
[12] 孙超, 朱滢, 柴海娜, 徐晓玲, 王璐, 陈超伍, 刘军. 内镜下冷圈套切除大肠小息肉在服用抗栓药物患者中的应用[J]. 中华消化病与影像杂志(电子版), 2021, 11(05): 200-203.
[13] 李佳莹, 张秋丽, 张修礼. 射频消融在早期肝癌治疗中的应用进展[J]. 中华消化病与影像杂志(电子版), 2021, 11(05): 226-228.
[14] 韩福健. 肠内营养支持治疗对老年慢性阻塞性肺疾病稳定期患者肺功能以及营养状况的影响[J]. 中华消化病与影像杂志(电子版), 2021, 11(04): 164-167.
[15] 郑长春. 系统性心理干预联合药物治疗消化性溃疡的临床疗效[J]. 中华消化病与影像杂志(电子版), 2021, 11(04): 168-172.
阅读次数
全文


摘要